The clinical genetics of phaeochromocytoma and paraganglioma
ABSTRACT Phaeochromocytoma and paraganglioma are rare catecholamine-producing tumours, recognised to have one of the richest hereditary backgrounds of all neoplasms, with germline mutations seen in approximately 30% of patients. They can be a part of genetic syndromes such as MEN 2 or Neurofibromato...
Main Authors: | P. T. Kavinga Gunawardane, Ashley Grossman |
---|---|
Format: | Article |
Language: | English |
Published: |
Brazilian Society of Endocrinology and Metabolism
|
Series: | Archives of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000500490&lng=en&tlng=en |
Similar Items
-
Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
by: A Al-Sharefi, et al.
Published: (2018-10-01) -
Stathmin Immunoreactivity in Phaeochromocytomas and Paragangliomas: Differential Expression Between Benign and Malignant Neoplasms
by: Wei-Chou Lin, et al.
Published: (2011-01-01) -
Glucose Intolerance on Phaeochromocytoma and Paraganglioma—The Current Understanding and Clinical Perspectives
by: Ichiro Abe, et al.
Published: (2020-11-01) -
Identification of Novel Mutations and Expressions of <i>EPAS1</i> in Phaeochromocytomas and Paragangliomas
by: Farhadul Islam, et al.
Published: (2020-10-01) -
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
by: David J. Pinato, et al.
Published: (2017-11-01)